CIBC World Markets’s United Therapeutics UTHR Stock Holding History

CIBC World Markets’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$726K	Buy	+1,491	New	+$694K	﹤0.01%	777
2025 Q2	$23.5M	Buy	81,777 +79,847	+4,137%	+$23.9M	0.15%	117
2025 Q1	$595K	Buy	1,930 +17	+0.9%	+$5.83K	﹤0.01%	919
2024 Q4	$675K	Sell	1,913 -543	-22%	-$200K	﹤0.01%	669
2024 Q3	$880K	Buy	2,456 +45	+2%	+$15.2K	0.01%	629
2024 Q2	$768K	Buy	2,411 +487	+25%	+$129K	0.01%	620
2024 Q1	$442K	Buy	1,924 +617	+47%	+$139K	﹤0.01%	735
2023 Q4	$287K	Buy	+1,307	New	+$301K	﹤0.01%	703
2021 Q2	–	Sell	-4,783	Closed	-$800K	–	946
2021 Q1	$800K	Buy	+4,783	New	+$797K	0.01%	664
2020 Q1	–	Sell	-38,400	Closed	-$3.38M	–	733
2019 Q4	$3.38M	Buy	+38,400	New	+$3.38M	0.02%	477

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

CIBC World Markets's UTHR Position: Q4 2025 in Review

CIBC World Markets opened a new position in United Therapeutics (UTHR) in Q4 2025: 1,491 shares worth $726K. The stake represents ﹤0.01% of the portfolio and ranks #777 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in UTHR as recently as Q2 2025.

CIBC World Markets first reported a position in UTHR in Q4 2019 and has held it in 10 quarters since. The position peaked at $23.5M in Q2 2025. 838 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.

CIBC World Markets held 1,491 shares of United Therapeutics worth $726K as of Q4 2025.
United Therapeutics was a new CIBC World Markets position in Q4 2025.
United Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #777 holding.
CIBC World Markets first reported a position in United Therapeutics in Q4 2019 and has held it in 10 quarters since.
CIBC World Markets's United Therapeutics position peaked at $23.5M in Q2 2025.
838 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.